Porphyromonas gingivalis outer membrane vesicles alter neuronal architecture and Tau phosphorylation in the embryonic mouse brain

Porphyromonas gingivalis (Pg) is an oral bacterial pathogen that has been associated with systemic inflammation and adverse pregnancy outcomes such as low birth weight and preterm birth. Pg drives these sequelae through virulence factors decorating the outer membrane that are present on non-replicative outer membrane vesicles (OMV) that are suspected to be transmitted systemically. Given that Pg abundance can increase during pregnancy, it is not well known whether Pg-OMV can have deleterious effects on the brain of the developing fetus. We tested this possibility by treating pregnant C57/Bl6 mice with PBS (control) and OMV from ATCC 33277 by tail vein injection every other day from gestational age 3 to 17. At gestational age 18.5, we measured dam and pup weights and collected pup brains to quantify changes in inflammation, cortical neuron density, and Tau phosphorylated at Thr231. Dam and pup weights were not altered by Pg-OMV exposure, but pup brain weight was significantly decreased in the Pg-OMV treatment group. We found a significant increase of Iba-1, indicative of microglia activation, although the overall levels of IL-1β, IL-6, TNFα, IL-4, IL-10, and TGFβ mRNA transcripts were not different between the treatment groups. Differences in IL-1β, IL-6, and TNFα concentrations by ELISA showed IL-6 was significantly lower in Pg-OMV brains. Cortical neuron density was modified by treatment with Pg-OMV as immunofluorescence showed significant decreases in Cux1 and SatB2. Overall Thr231 was increased in pups exposed to Pg-OMV with the appearance of a secondary band of 60 kD. Together these results demonstrate that Pg-OMV can significantly modify the embryonic brain and suggests that Pg may impact offspring development via multiple mechanisms.


Introduction
Pregnancy induces significant changes in mothers including shifts in the abundance of oral bacteria (1)(2)(3)(4).Increased blood flow and pregnancy related hormones allows for the growth of pathogens like Porphyromonas gingivalis (Pg) an organism associated with oral infections that are increasingly linked to adverse pregnancy and neurodevelopmental outcomes (5)(6)(7).Increased Pg presence is estimated to be prevalent in 40% of pregnancies in the US and 2-11% worldwide (8,9).This presence of bacteria sometimes resulting in periodontitis, a significant dental infection, can drive systemic inflammation (10)(11)(12).Preterm birth, preeclampsia, and low birth weight are well-characterized effects of maternal Pg infections and Pg DNA has been detected in the placenta and amnionic fluid.Pg driven outcomes affecting children have focused on pregnancy outcomes (13)(14)(15)(16)(17)(18) and only recently has Pg received attention as a modulator of fetal development and remains an understudied host-pathogen interaction (19,20).
P. gingivalis has been extensively studied to determine its role in modifying pregnancy.
Rodent models of Pg infection demonstrate that exposure to Pg can result in systemic inflammation, low birth weight and pre-term delivery (21)(22)(23)(24)(25). Pg mediates these and other effects thorough a number of virulence factors that modify host responses including lipopolysaccharide (LPS) and proteases known as gingipains (26)(27)(28)(29)(30)(31)(32).Both are also present on the surface of OMV that are now suspected to be transmitted systemically in the blood stream (20,32,33).LPS and the gingipains interact with the immune system but are unique compared to other gram-negative bacteria.For instance, Pg LPS is less immunogenic than Escherichia coli LPS but also causes inflammation and the production of pro-inflammatory cytokines (34,35).The gingipains are unique to Pg and they modify cytokine expression that allows Pg to evade the host immune response and establish periodontal infections that drive systemic inflammation (36)(37)(38)(39).Pg infection also modifies the placenta to cause spiral artery remodeling that can result in a hypoxic state linked to preeclampsia and fetal growth restriction (40).However, whether Pg-OMV may induce fetal growth restriction-a common outcome in animal models and humans with Pg infections of clinical significance-is not yet known.
P. gingivalis is associated with maternal inflammation and adverse pregnancy outcomes that increase the risk of modified developmental trajectories of offspring (17,41).Live Pg is well demonstrated to increase inflammation in animal models and exposure to Pg-OMV recapitulates these observations as the vesicles harbor the same virulence factors.Ishida et al. reported increased Iba-1 indicative of microglia activation and modified neuroarchitecture in E 20 pup brains from dams with an established Pg infection prior to pregnancy (19).These alterations were accompanied by declines in cognitive ability, and it was suggested the combined effects on the embryonic brain resulted in neuroinflammation that drove these changes.Similarly, Gong et al. described a neuroinflammatory phenotype in adult mice where exposure to Pg-OMV for 3 months increased IL-1β and NLRP3 expression concurrent with modification of the neuroarchitecture and behavior (33).Together these studies suggest that long-term exposure to Pg and Pg-OMV can result in immune phenotypes indicative of a proinflammatory response that would be expected from activated microglia in the M1 activation state (42,43).However, the maternal immune system functions differently than the non-pregnant state and changes in inflammation and neuroarchitecture related to pathogen exposure in utero after pregnancy is established may also differ.This knowledge gap limits our efforts to refine predictions of the potential impact of pathogendriven inflammation on the developmental trajectory of offspring.
Proper function is dependent on phosphorylation that can occur at multiple sites and can be modified by inflammation and exposure to pathogens such as Pg (47)(48)(49).Phosphorylated Tau (p-Tau) has less affinity for tubulins and self-aggregates into βamyloid plaques that are a hallmark of neuroinflammatory diseases such as Alzheimer's and Parkinson's diseases in older adults (50).The resulting Tau tangles can trigger an immune response that is sustained through microglial NFκβ signaling and thus are considered pathogenic forms of the protein (51,52).In a mouse model, Gong et al. showed that Pg-OMV alter the Tau profile and could result in β-amyloid plaques accompanied by increased inflammation (33).However, relatively less is known about the role of p-Tau in the developing brain and whether exposure to pathogens during pregnancy alters this profile.A survey of fetal and adult Tau phosphorylation in humans demonstrated significant overlap in p-Tau where some of the pathogenic forms of Tau in adults with Alzheimer's disease were also prevalent in the fetal brain suggesting p-Tau in children does not have a pathogenic effect as observed in adults (53).Interestingly, Tau is hyperphosphorylated in the embryonic rodent brain but knock-down of Tau during gestation in mice can reduce neuronal migration to all cortical layers indicating that p-Tau is an important part of normal brain development in mice (47,49,54).Whether or not Pg-OMV may modulate Tau phosphorylation in developing brains in utero is an open question.Addressing this knowledge gap may provide valuable insight into the mechanisms by which Pg is able to modify developmental trajectories of children.
Herein, we describe a study to determine the effect of Pg-OMV on the developing mouse brain to understand this host-pathogen interaction that frequently occurs in the human population.To simulate a maternal infection with Pg, pregnant C57/Bl6 mice were exposed to a consistent dose of Pg-OMV via tail vein injection.At gestational age (GA) 18.5, inflammatory responses, concentration of Tau Thr231 (Thr231) and neuron density in the cortices of embryonic pup brains were assessed to augment the understanding of Pg-modulated brain development that may be relevant to pathogen exposure during pregnancy.

Pup Body and Brain Weights
Previous studies in mice have demonstrated that dams with Pg infection or those consistently dosed with Pg bacteria during pregnancy can result in low birth weight of pups.We recorded weight of the dams, pups, and pup brains at GA 18.5 (Fig 1A) to determine whether exposure to Pg-OMV would have the same effect.Dam and pup weights were not significantly different in PBS and Pg-OMV groups (Fig 1B and 1C) but there was a significant decrease in the pup brain weight after 14 days of Pg-OMV treatment (Fig 1D, Mann-Whitney U p = 0.023,).We included an assessment of Hif1a as Pg is known to cause hypoxia in mouse models that is related to fetal growth restriction.
Relative expression of HiF1a in the embryonic mouse brain was not significantly different between the control and treated groups indicating the OMV did not induce a hypoxic state in utero that could account for the decreased pup brain weights (Fig 1E).

Inflammation
Maternal inflammation can affect the developing embryo in mouse models, and we tested whether exposure to Pg-OMV during pregnancy would result in an inflammatory response concordant with increased presence of pathogens experienced during pregnancy.First, we assessed the concentration of Iba-1 as a surrogate of microglia activation and established this immune cell typically involved in pathogen defense was active in the embryonic mouse brain.Western blotting of whole brain homogenates showed that Iba-1 was significantly increased in Pg-OMV pup brains compared to PBS controls (Fig 2A and 2B, Mann-Whitney U p = 0.0003).Next, we tested whether increased Iba-1 was accompanied by increased concentration and expression of pro-inflammatory cytokines IL-1β, IL-6 and TNFα indicative of M1 activation that produces a pro-inflammatory response.ELISA quantification showed that PBS pups typically had higher levels of cytokines but only IL-6 was significantly greater in the PBS brains compared to pups from the Pg-OMV group (Fig 3D, Student's T-test p = 0.002).The levels of IL-1β and TNFα showed similar trends but were not statistically different between the treatment groups (Fig 3A, 3D, 3G, p > 0.05 in all cases).We extended this analysis to include effects that may be apparent at the level of expression in the embryonic brain tissue.RT-qPCR analysis of these cytokines showed no significant difference between the PBS and Pg-OMV pups.Then, we tested the possibility that increased Iba-1 could result in an M2 or anti-inflammatory immune response given that microglia can be in two broad functional categories (42,55).Analysis of IL-4, IL-10 and TGFβ typical of M2 activated microglia were not significantly different between the treatment groups ( We were interested in identifying potential modifications in cytokine concentration and expression that may differ between female and male offspring as maternal inflammation may have sex specific effects.When parsed by sex, we observed that IL-6 and IL-1β

Neuroarchitecture
Without a strong inflammatory phenotype, we tested the possibility that Pg-OMV treatment could nonetheless result in differences in the neuroarchitecture of the developing mouse brain.We examined the distribution of neuronal proteins Cux1, SatB2, and Ctip2 that are differentially expressed across the layers of the cortex in sagittal sections of embryonic mouse brains.The distribution and density of these proteins were modified by exposure to Pg-OMV compared to pups from the PBS group (Fig 5A and 5B).
We saw significant decreases in Cux1 (Student's T-test p = 0.03) and SatB2 (Students Ttest p = 0.0001) signal intensity but not Ctip2 (Student's T-test p = 0.064) although it also followed a similar downward trend in the Pg-OMV pup brains (Fig 5B).These findings suggests that cortical layering was drastically altered in Pg exposed animals.

Tau Thr231
We evaluated whether Tau phosphorylated at Thr231 in GA 18.

Discussion
Animal models of Pg infection demonstrate modified pregnancy outcomes and can alter birth weight of offspring.Our experimental design did not recapitulate these observations as pup weights in the Pg-OMV group were not statistically different from PBS controls.
Moreover, dam weights were also unchanged indicating that food and water intake were likely not different between the control and treatment groups.The mechanism behind reduced brain weight is not clear from our observations, although pup weight followed a similar downward trend suggesting that the effect of Pg-OMV was systemic for the developing embryos.It could be possible that exposure to pathogens after initiation of pregnancy is different from a state where the pathogen is already present and interacting with host defense mechanisms.Likewise, the dosage of Pg-OMV we used may have not been sufficient to recapitulate the full effect of Pg on pregnancy outcomes, where more robust responses of the host and fetus may be required to lower birth weights.This would coincide with unchanged expression of Hif1a.Nevertheless, treatment with a low dosage of Pg-OMV during pregnancy impacted the development of the embryonic brain that could have implications after birth.
P. gingivalis and Pg-OMV induced neuroinflammation is suspected to be involved in cognitive decline in aging cohorts and have a significant impact on development in utero.
Our hypothesis that Pg-OMV would produce a pro-inflammatory response in the embryonic mouse brain was not observed.Cytokine concentrations and levels of mRNA transcripts in the pup brains tended to be lower in the Pg-OMV group.The lack of concordance with previous work was somewhat unexpected as most reports demonstrate systemic inflammation upon exposure to Pg or its OMV.Significant increases of Iba-1 in Pg-OMV exposed brains indicates sensing of bacterial-derived components, such as LPS, that can stimulate immune response, though this was not accompanied by a significant increase in cytokine production in our mice.Moreover, Pg has atypical LPS compared to organisms like E. coli LPS, that can bind to TLR-4, but can be recognized by alternative sensing pathways.We addressed this possibility by quantifying the expression of MYD88 and NLRP3 inflammasome mRNAs that are known to increase upon exposure to Pg or Pg-OMV.Our analysis found that concentrations of both were unaffected by OMV treatment in GA 18.5 pup brains and we posit several factors may be influencing our data.First, our results could originate from the delivery of Pg-OMV via tail vein injection which bypass sensing mechanisms such as dendritic cells of the gastrointestinal tract that would detect Pg and LPS being translocated from the oral cavity in saliva.Second, it is equally possible that Pg-OMV induced inflammation reported elsewhere may be an outcome in adult mice with long-term exposure to Pg or Pg-OMV but may not necessarily be an outcome for exposure after pregnancy has been established given the maternal immune system functions differently compared to the prepregnancy state.Thus, our observations may not be comparable to reports that use Pg infection or treatment with Pg or Pg-OMV at high doses over several weeks prior to inducing pregnancy.Importantly, the dosing scheme described here suggests there is a potential use of Pg-OMV as a proxy for bacteria to study effects on fetal tissues independent of systemic inflammation driven by common oral pathogens that become more prevalent during pregnancy.More work is needed to elucidate how the timing and dosage of pathogen exposure relative to the start of pregnancy modulates immune responses during gestation that could be associated with long-term consequences for offspring in human populations.
Several reports have quantified the impact of Pg and Pg-OMV on neurons as this cell type is affected by inflammation and is important in brain development.Our data indicate that Pg-OMV have a significant impact on neurons as their prevalence was modified in the cortical layers of the embryonic brain.Cux1, SatB2, and Ctip2 signals were lower overall and showed modified distribution in the Pg-OMV exposed brains compared to controls.The down regulation of SatB2 and Cux1 are particularly interesting as abnormal expression of both are associated with altered behavior in mice and are suspected to be a contributor to autism spectrum disorder-like symptoms in humans.Likewise, deficiencies in Cux1 expression have been linked to neurodevelopmental delays, while down regulation of Ctip2 is known to affect axonal growth and is involved in spiny neuron differentiation.The neuroarchitectural changes observed herein are aligned with previous studies, yet novel because these cortical layer aberrations were not accompanied by any indication of systemic inflammation.Collectively, these data suggest that Pg, or perhaps Pg-OMV specially, affect the developing brain through a different mechanism.Parsing out the effects of Pg-OMV on cell proliferation and migration appears to be critical in deciphering how Pg mediates effects on the developing brain and should be addressed in future studies to better understand this important host-pathogen interaction.
The importance of Tau in the developing brain has not been fully described but our observations indicate exposure to Pg-OMV can alter the amount of Thr231 in mouse embryos.Tauopathies have multiple effects on the central nervous system including sustained inflammation through NFκβ signaling microglia that detects the pathogenic form of Tau in adult animal models.Our data would appear to support the notion that Thr231 in the embryonic mouse brain is not pathogenic as an innate immune response, concordant with an inflammation-based hypothesis of neurodegenerative phenotypes, was not observed.Accordingly, we did not observe an increase in NFκβ that can encourage transcription of cytokines.We did not perform a comprehensive assessment of Tau phosphorylation sites, nor did we specifically address potential interactions between p-Tau and microglia.Nonetheless, the alteration of Thr231 abundance aids in explaining how changes in neuron migration and axon growth may result from exposure to Pg in utero; our observed changes in cortical layer markers could be the result of altered microtubule binding driven by altered p-Tau.Thus, much work remains to be done in elucidating the role of Pg and Pg-OMV on human neurodevelopment and cognitive trajectories from the early to elderly phases of life.

OMV Isolation
Porphyromonas gingivalis strain ATCC 33277 was grown in anaerobic conditions (85% N2, 10% CO2, 5% H2) using Tryptic Soy Broth (Difco cat# 211768) medium supplemented with 5.0 mg ml-1 hemin (Thermo Fisher, cat# AAA1116503), 1.0 mg ml -1 menadione (MP Biomedicals, cat # 102259), and 0.5 g L -1 L-cysteine-HC (MP Biomedicals, cat # 101446).A cleared supernatant was produced by pelleting cells at 8000 rpm for 15 minutes followed by filtration of the supernatant through a 0.45 um membrane filter under low vacuum pressure.Using Sorvall 11.5mL ultracentrifuge tubes and ultracrimp tube plugs, filtered supernatant was ultacentrifuged at 65,000 rpm for 1 hour at 4°C using a Sorvall WX Ultra 80 centrifuge.Immediately after centrifugation, supernatant was discarded and the pellet containing the OMV was resuspended in 500uL of PBS (56).The total protein of the OMV were quantified using the Pierce BCA assay with BSA as a standard and stored at -20°C for future use.

Animal Breeding, Dosing and Tissue Collection
2-3 month old C57/Bl6 mice (male and female) were purchased from Jackson Labs (Maine, USA).All animals were housed in the animal research core under 12 h light/dark cycles.Mice were bred and dams were checked for plugs 2x/day.Once a plug was visible, the dam was removed and was marked as gestational day 0 (GA 0).Starting at E3, 50 µg Pg OMV were administered via tail vein injection every other day until GA 18.5.An equal volume of sterile PBS was used for the control group.Pregnant dams were anesthetized using isoflurane and pups were removed via C-sections.C Pups were decapitated and whole brain and placenta were collected from each pup.Half of the pup brains were randomly chosen and fixed using 4% paraformaldehyde followed by 30% sucrose prior to being mounted in O.C.T. and frozen for Immunohistochemical and Immunofluorescent analysis.The remaining brains were snap frozen in a liquid N2 at time of collection and used for protein, RNA, and DNA extraction.Fixed tissues were stored at 4°C and frozen tissues were stored at -80°C.All experimental procedures were approved by the IACUC under protocol AR21-00010.

Protein Extraction, Western Blotting and ELISA
Protein from snap-frozen whole brains were extracted using RIPA Buffer (cell signaling) with protease inhibitor cocktail (ThermoFisher).Concentration was determined prior to loading using the Pierce BCA Assay Kit (ThermoFisher) with subsequent colorimetric detection using BioTek Synergy H1 microplate reader.Samples were denatured in Laemmli buffer at 95°C for 5 min.50 µg total protein from each sample was loaded onto 10% Mini-PROTEAN® TGX™ Precast Protein Gels (Bio-Rad) and separated for 1 h at 150 V. Proteins were transferred onto nitrocellulose or PVDF membranes using Turbo transfer (Bio-Rad) for 7 min at 2.5 A. Membranes were incubated in Everyblot blocking buffer (Bio-Rad) for 1 h at RT.For Iba-1 probe, membranes were cut at 37 kDa marker and lower half was incubated with Iba1, top half was incubated with b-actin.For p-Tau, membranes were cut between 75 and 100 kDa marker.Top half was incubated with vinculin, bottom half was incubated with phospho-Tau (Thr231) from Cell Signaling (cat # 71429).All primary antibody incubations were overnight at 4°C.Membranes were washed in 1X Tris-buffered saline with 0.1% Tween-20 (TBST) prior to a secondary incubation with either goat anti-mouse HRP or goat anti-rabbit HRP at a dilution of 1:3000 for 1 h at RT. Membranes were washed a second time with 1X TBST prior to a 5 min incubation in ECL reagent (superSignal west pico plus ECL substrate kit).Blots were imaged on a Bio-Rad Chemidoc.Densitometric analysis was performed in ImageLab Software (Bio-Rad).
Target signals were normalized to a control protein on each blot of either Vinculin or βactin.Aliquots of the RIPA extracted proteins (from above) were used to quantify the cytokines by ELISA for IL-1β (Invitrogen IL-1 beta Mouse ELISA kit, cat # BMS6002), IL-6 (Invitrogen IL-6 Mouse ELISA kit, cat # BMS603-2) and TNFα (Invitrogen TNF alpha Mouse ELISA kit, cat # BMS607-3), from whole brains according to manufacturer's protocol.All samples were run in duplicate.The average from both wells was used for quantification.Original western blots can be found in Supporting information S1 and S2.

Nucleic Acid Extraction, PCR, and RT-qPCR
DNA and RNA was extracted for sexing embryonic mice and RT-qPCR analysis of cytokine mRNAs present in the pup brains.Nucleic acids were extracted from frozen whole brains using the Omega Bio-tek E.Z.N.A. kit according to manufacturer's protocol (cat# R6731-01).RNA and DNA concentrations were determined using Qubit Fluorometer (Applied Biosystems) prior to subsequent analysis.For sexing of pups we added 1µL DNA to a reaction with the Q5 Master Mix (NEB, cat# M04925 ) and primer sets for amplification of the IL3 (For 5'-GGG ACT CCA AGC TTC AAT CA-3', Rev 5'-TGG AGG AAG AAA AGC AA-3') and Sry (For 5'-TGG GAC TGG TGA CAA TTG TC, Rev 5'-GAG TAC AGG TGT GCA GCT CT-3') genes (57).PCR conditions were 95°C for 4.5 min followed by 33 cycles of 95°C for 35 s, 50°C for 1 min and 72°C for 1 min.PCR products were terminated with a final extension at 72°C for 5 min.Bands positive for both are labeled as male while samples only expressing IL3 are labeled as female.cDNAs for RT-qPCR were made by adding 1000 ng RNA to a reaction using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, cat# 4368814).1µL of cDNA was added per reaction with gene specific primer pair sets for GAPDH, IL-1β, IL-6, TNFα, IL-4, IL-10, TGFβ, MyD88, NFκβ, and NLRP3 (Integrated DNA Technologies, PrimeTime qPCR Primer Assay).All samples were run in triplicate on a QuantStudio6 Pro (Applied Biosystems) using the PowerUp SYBR Green Master Mix (ThermoFisher, cat # A25741).Cycling conditions are as follows: 95°C for 15s followed by 60°C for 1 min for 40 cycles.Gene expression was measured using the QuantStudio6 Pro detection system and normalized to GAPDH.Ct values were averaged from each triplicate and used to calculate the relative expression by the 2^- (ΔΔCt) method with GAPDH as the reference gene.

Immunofluorescent Staining
Fixed brains were embedded in OCT medium and 25 µm sagittal sections were collected by a cryostat.Sections were washed with PBS, blocked in PBS containing 0.1% tritonX-100, and 10% donkey serum and probed with and primary antibodies to Cux1 (Protein Tech 11733-1-AP; diluted 1:300), SatB2 (Abcam ab92446; diluted 1:100), and Ctip2 (Abcam ab-18465; diluted 1:500).Sections were then washed with PBS and incubated with Alexa Fluor® secondary antibodies (Thermo Fisher Scientific Fig 3 C, 3F, 3I, p > 0.05 in all cases).Lastly, given these results we tested whether the expression of NLRP3, MyD88 and NFκβ, which can be modified by exposure to Pg or it's OMV, were also modified in our pups.RT-qPCR analysis of MyD88 and NLRP3 transcripts (Fig 4) had similar downward trends with Pg-OMV treatment but were not significantly different compared to controls (Fig 4A, and 4B, p > 0.05 in both cases).Interestingly, NFkβ transcripts that are typically reported as being upregulated by Pg were significantly decreased in the Pg-OMV group (Fig 4C, Student's T-test p = 0.004).
concentrations were significantly lower in female pups from the Pg-OMV group compared to the female controls (Fig 3A, Mann-Whitney U test p = 0.04 and 3D, Student's T-test p = 0.0095) and though TNFα was lower in Pg-female pups, it was not statistically different in our analysis (Fig 3A, 3D.3G).The effect of Pg-OMV on transcription was highly variable for IL-1β, TNFα, IL-4, IL-10 and TGFβ but generally trended upwards (Fig 3B-3I) for the female pups.Trends in the males were similar but were not significant and likely result from low sample sizes (Fig 3), though we could not assess difference in cytokine concentrations as the Pg male group had only 2 observations (Fig 3A, 3D, 3G).
5 mouse brains was affected by exposure to Pg-OMV during gestation as this is one form of p-Tau implicated in neuroinflammatory diseases.Western blotting of proteins from whole brain homogenates showed Thr231 was present in PBS and Pg-OMV mouse brains at approximately 50 kD indicating that at this amnio acid, Tau was in a phosphorylated state concordant with other observations of Tau in the developing mouse brain (Fig 6A).We observed that an additional band at 60kD became more prominent in the Pg-OMV brains compared to controls (Fig 6A).Quantification of these bands showed that both the 50kD and 60kD bands were significantly greater in the brains from Pg-OMV exposed mice compared to the PBS control group (Fig 6B, 50 kD Student's T-test p = 0.003, 60kD Student's T-test p = 0.0006).The increased abundance of both (e.g.50kD signal + 60kD signal = total Thr231) lead to significant overall increase of Thr231 in the Pg-OMV group (Fig 6B, total Thr231, Student's T-test p = 0.001) indicating Pg-OMV may alter the total concentration and diversity of Thr231 isoforms during development in our mice.
) and DAPI followed by mounting with Prolong Diamond Antifade (Thermo Fisher Scientific).Images were acquired with an ImageXpress Micro Confocal High Content Imaging System (IXMC; Molecular Devices) and analyzed using MetaXpress software (Molecular Devices).

1 AFig 3 .Fig 6 .
Fig 3. Altered neuronal development observed in the cortex of mice exposed to Pg OMVs in utero.(A) Representative images of cortical sections probed with antibodies to Cux1, SatB2, and Ctip2, followed by DAPI and secondary antibodies conjugated to FITC, Cy5, and respectively, to examine neurogenesis within the developing cortex.(B) Ratios of indicated fluorescence vs DAPI from at least 3 different sections from 5 different litters are shown.Error bars represent the SEM.**P<0.005;****P<0.0001.